HCA Healthcare, Inc. (HCA) Form 10-Q — Oct 29, 2026
HCA Healthcare reported Q3 2026 revenues of $19.849 billion, up 3.6% year over year, driven by a 2.8% increase in equivalent admissions and 0.7% higher revenue per equivalent admission. Same-facility revenue growth matched the consolidated pace at 3.6%. Net income attributable to HCA fell 3.9% to $1.579 billion, or $7.27 per diluted share, versus $1.643 billion, or $6.96, a year ago. Margins were pressured by a 27.2% jump in uninsured admissions following the expiration of enhanced premium tax credits at the end of 2025, a rise in other operating expenses, and higher interest expense on a larger debt load.
Key figures
- Eps
- 7.27
- Revenue
- 19849000000
- Guidance
- Planned capital expenditures expected to be between $5.0 billion and $5.5 billion in 2026, excluding acquisitions
- Net Income
- 1579000000
- Total Debt
- 50493000000
- Revenue Yoy
- 3.6%
- Total Assets
- 63452000000
- Cash Position
- 908000000
- Capex 9m
- $3.707 billion
- Dividend per share
- $0.78 quarterly
- Nine month revenue
- $59.188 billion (up 5.5% YoY)
- Nine month eps diluted
- $22.05 vs $20.23 prior year
- Average debt balance q3
- $49.743 billion
- Shares repurchased 9m 2026
- 15.139 million shares for $6.605 billion
- Total uncompensated cost q3
- $1.477 billion vs $1.188 billion prior year
- Uninsured admissions growth q3
- 27.2% consolidated
- Buyback authorization remaining
- $4.240 billion
- Same facility revenue growth q3
- 3.6%
- Consolidated admissions growth q3
- 2.5%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.